comparemela.com

Latest Breaking News On - Saphyr systems - Page 1 : comparemela.com

Bionano Genomics, Inc (NASDAQ:BNGO) Q2 2023 Earnings Call Transcript

Operator: Good day, and welcome to the Bionano s Second Quarter 2023 Earnings Conference Call. Today s conference is being recorded.

United statesMark massaroDaniel hultbergJason mccarthyErik holmlinFrancois briseboisMichael okunewitchJi namDavid holmesChris stewartBionano innovator research programIsrael ministry of healthNxclinical softwareBionano genomics incWorld health organizationMaxim group

Bionano Genomics (BNGO) Q2 2023 Earnings Call Transcript

BNGO earnings call for the period ending June 30, 2023.

United statesMark massaroMichael okunewitchJason mccarthyChris stewartDavid holmesJi namFrancois briseboisErik holmlinJi nam scotiabankDaniel hultberg oppenheimerMaxim groupDuke universityNational comprehensive cancer networkJason mccarthy maxim group analystMichael okunewitch maxim group analyst

Bionano Genomics, Inc (NASDAQ:BNGO) Q1 2023 Earnings Call Transcript

Operator: Good day and welcome to the Bionano Genomics First Quarter 2023 Earnings Conference Call. Today s conference is being recorded.

United statesChris stewartFrancois briseboisMichael okunewitchErik holmlinAlka chaubeyDavid holmesJeff cohenBionano genomics incNxclinical softwareMd anderson cancer centerChina national medical products administrationMaxim groupWorld health organizationGenome precision technologyNational comprehensive cancer network

Bionano Genomics, Inc (BNGO) CEO Erik Holmlin on Q2 2022 Results - Earnings Call Transcript

Bionano Genomics, Inc. (NASDAQ:NASDAQ:BNGO) Q2 2022 Results Conference Call August 04, 2022 04:30 PM ET Company Participants Amy Conrad - Investor Relations Erik Holmlin - Chief Executive.

San diegoUnited statesComunidad autonoma de catalunaChristopher stewartJason mccarthyErik holmlinShamanna kanagalAmy conradChris stewartMichael okunewitchCompany participantsLaboratory developedCompany investor relationsBionano genomics incJose carreras instituteCancer genomics consortium

vimarsana © 2020. All Rights Reserved.